Cargando…

Sociodemographic correlates of 25-hydroxyvitamin D test utilization in Calgary, Alberta

BACKGROUND: Increasing laboratory test utilization is a major challenge facing clinical laboratories. However, in most instances we lack population level information on the patient groups to which increased testing is directed. Much recent work has been published on the sociodemographic correlates o...

Descripción completa

Detalles Bibliográficos
Autores principales: de Koning, Lawrence, Henne, Dan, Woods, Paul, Hemmelgarn, Brenda R, Naugler, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132197/
https://www.ncbi.nlm.nih.gov/pubmed/25106954
http://dx.doi.org/10.1186/1472-6963-14-339
_version_ 1782330579024347136
author de Koning, Lawrence
Henne, Dan
Woods, Paul
Hemmelgarn, Brenda R
Naugler, Christopher
author_facet de Koning, Lawrence
Henne, Dan
Woods, Paul
Hemmelgarn, Brenda R
Naugler, Christopher
author_sort de Koning, Lawrence
collection PubMed
description BACKGROUND: Increasing laboratory test utilization is a major challenge facing clinical laboratories. However, in most instances we lack population level information on the patient groups to which increased testing is directed. Much recent work has been published on the sociodemographic correlates of 25-hydroxyvitamin D deficiency. An unanswered question, however, is whether testing is preferentially directed towards individuals with a higher likelihood of deficiency. In this paper we examine this question by combining laboratory information system data on testing rates with Census Canada data. METHODS: We examined 1,436 census dissemination areas within the city of Calgary, Alberta, Canada. For each census dissemination area we determined age and sex-specific 25-hydroxyvitamin D testing rates over a one year period. We then compared these testing rates with the following sociodemographic variables obtained from Census Canada: first nations status, education level, household income, visible minority status, and recent immigrant status. RESULTS: Overall, 6.9% of males in the city of Calgary were tested during the study period. Females were 1.7 times more likely to be tested than males. Testing rate increased with increasing age, with 16.8% of individuals 66 years and over tested during the one-year study period. Individuals having at least some university education were less likely to be tested (RR = 0.60; p < 0.0001). Interestingly, although visible minorities were over twice as likely to be tested as compared to non-visual minorities (RR = 2.25; p < 0.0001), recent immigrants, a group known to exhibit low 25 hydroxyvitamin D levels, were significantly less likely to be tested than non-recent immigrants (RR = 0.72; p = 0.0174). While median household income was modestly associated with increased testing (RR = 1.02; p < 0.0001), First Nations status and non-English speaking were not significant predictors of 25-hydroxyvitamin D testing. CONCLUSIONS: Testing for 25-hydroxyvitamin D is in part directed toward populations at higher risk of deficiency (visible minorities) and at higher risk of osteoporosis (older females), but a particularly high risk group (recent immigrants) is being tested at a lower rate than other patient groups.
format Online
Article
Text
id pubmed-4132197
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41321972014-08-15 Sociodemographic correlates of 25-hydroxyvitamin D test utilization in Calgary, Alberta de Koning, Lawrence Henne, Dan Woods, Paul Hemmelgarn, Brenda R Naugler, Christopher BMC Health Serv Res Research Article BACKGROUND: Increasing laboratory test utilization is a major challenge facing clinical laboratories. However, in most instances we lack population level information on the patient groups to which increased testing is directed. Much recent work has been published on the sociodemographic correlates of 25-hydroxyvitamin D deficiency. An unanswered question, however, is whether testing is preferentially directed towards individuals with a higher likelihood of deficiency. In this paper we examine this question by combining laboratory information system data on testing rates with Census Canada data. METHODS: We examined 1,436 census dissemination areas within the city of Calgary, Alberta, Canada. For each census dissemination area we determined age and sex-specific 25-hydroxyvitamin D testing rates over a one year period. We then compared these testing rates with the following sociodemographic variables obtained from Census Canada: first nations status, education level, household income, visible minority status, and recent immigrant status. RESULTS: Overall, 6.9% of males in the city of Calgary were tested during the study period. Females were 1.7 times more likely to be tested than males. Testing rate increased with increasing age, with 16.8% of individuals 66 years and over tested during the one-year study period. Individuals having at least some university education were less likely to be tested (RR = 0.60; p < 0.0001). Interestingly, although visible minorities were over twice as likely to be tested as compared to non-visual minorities (RR = 2.25; p < 0.0001), recent immigrants, a group known to exhibit low 25 hydroxyvitamin D levels, were significantly less likely to be tested than non-recent immigrants (RR = 0.72; p = 0.0174). While median household income was modestly associated with increased testing (RR = 1.02; p < 0.0001), First Nations status and non-English speaking were not significant predictors of 25-hydroxyvitamin D testing. CONCLUSIONS: Testing for 25-hydroxyvitamin D is in part directed toward populations at higher risk of deficiency (visible minorities) and at higher risk of osteoporosis (older females), but a particularly high risk group (recent immigrants) is being tested at a lower rate than other patient groups. BioMed Central 2014-08-09 /pmc/articles/PMC4132197/ /pubmed/25106954 http://dx.doi.org/10.1186/1472-6963-14-339 Text en Copyright © 2014 de Koning et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research Article
de Koning, Lawrence
Henne, Dan
Woods, Paul
Hemmelgarn, Brenda R
Naugler, Christopher
Sociodemographic correlates of 25-hydroxyvitamin D test utilization in Calgary, Alberta
title Sociodemographic correlates of 25-hydroxyvitamin D test utilization in Calgary, Alberta
title_full Sociodemographic correlates of 25-hydroxyvitamin D test utilization in Calgary, Alberta
title_fullStr Sociodemographic correlates of 25-hydroxyvitamin D test utilization in Calgary, Alberta
title_full_unstemmed Sociodemographic correlates of 25-hydroxyvitamin D test utilization in Calgary, Alberta
title_short Sociodemographic correlates of 25-hydroxyvitamin D test utilization in Calgary, Alberta
title_sort sociodemographic correlates of 25-hydroxyvitamin d test utilization in calgary, alberta
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132197/
https://www.ncbi.nlm.nih.gov/pubmed/25106954
http://dx.doi.org/10.1186/1472-6963-14-339
work_keys_str_mv AT dekoninglawrence sociodemographiccorrelatesof25hydroxyvitamindtestutilizationincalgaryalberta
AT hennedan sociodemographiccorrelatesof25hydroxyvitamindtestutilizationincalgaryalberta
AT woodspaul sociodemographiccorrelatesof25hydroxyvitamindtestutilizationincalgaryalberta
AT hemmelgarnbrendar sociodemographiccorrelatesof25hydroxyvitamindtestutilizationincalgaryalberta
AT nauglerchristopher sociodemographiccorrelatesof25hydroxyvitamindtestutilizationincalgaryalberta